Transglutaminase 3 Reduces the Severity of Psoriasis in Imiquimod-Treated Mouse Skin

Int J Mol Sci. 2020 Feb 25;21(5):1566. doi: 10.3390/ijms21051566.

Abstract

Four transglutaminase (TG) isoforms have been detected in epidermal keratinocytes: TG1, TG2, TG3, and TG5. Except for TG1 and TG3, their contribution to keratinocyte development and structure remains undefined. In this paper, we focused on the roles of TG2 and TG3 in imiquimod-induced psoriasis in mouse skin. We evaluated the severity of psoriasis markers in the skin of imiquimod-treated TG3 null and TG2 null mice. Our results showed that compromised TG3KO mouse skin was more responsive than WT or TG2KO mouse skin to the action of the pro-inflammatory drug imiquimod.

Keywords: TG2KO; TG3KO; imiquimod; inflammation; psoriasis; skin; transglutaminase 2; transglutaminase 3.

MeSH terms

  • Animals
  • GTP-Binding Proteins / genetics
  • GTP-Binding Proteins / metabolism*
  • Imiquimod / toxicity
  • Keratinocytes / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Protein Glutamine gamma Glutamyltransferase 2
  • Psoriasis / etiology
  • Psoriasis / genetics
  • Psoriasis / metabolism*
  • Transglutaminases / genetics
  • Transglutaminases / metabolism*

Substances

  • Protein Glutamine gamma Glutamyltransferase 2
  • Transglutaminases
  • GTP-Binding Proteins
  • Imiquimod